Elif Bacak Güllü

Elif Bacak Güllü

Auto-generated profile, based on publicly available information

Elif Bacak Güllü

Vocational School of Technical Sciences, Gaziantep University

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 August 2023 in European Journal of Environmental and Civil Engineering
Verified
Journal Article
Closed access
HGHamza Güllü
Hamza Güllü
MYMehmet Emin Yetim
Mehmet Emin Yetim
EGElif Bacak Güllü
Elif Bacak Güllü

11 March 2025 in European Journal of Environmental and Civil Engineering
Verified
Journal Article
Closed access
HGHamza Güllü
Hamza Güllü
MYMehmet Emin Yetim
Mehmet Emin Yetim
EGElif Bacak Güllü
Elif Bacak Güllü

1 January 2013 in Kafkas Universitesi Veteriner Fakultesi Dergisi
Verified
Journal Article
Closed access
GAGülcan Avci
Gülcan Avci
EGElif Bacak Güllü
Elif Bacak Güllü

15 February 2024 in International Journal of Clinical Biochemistry and Research
Verified
Journal Article
Open access
PDF file
HÇHülya Çiçek
Hülya Çiçek
AKAbdalrhman Kuba
Abdalrhman Kuba
MUMete Gürol Uğur
Mete Gürol Uğur
EGElif Bacak Güllü
Elif Bacak Güllü
NTNeslihan Tepe
Neslihan Tepe
Preeclampsia is a disease characterized by hypertension, proteinuria, and edema that occurs after the 20th gestational week. It is among the most important reasons for maternal/perinatal morbidity and mortality. Although many studies have been carried out, the pathophysiology of the disease is not fully known. Many methods have been proposed for evaluating risk factors leading to preeclampsia. In the past, the methods used to predict preeclampsia have usually been focused on non-biochemical markers, but nowadays there is a shift towards biochemical markers. Recently, many biochemical agents have been started to be used in the prediction of preeclampsia. In this study, the evaluation of some serum biomarkers in the follow-up preeclampsia was aimed. Serum nesfatin, ezrin, placental protein 13, hypoxia-inducible factor 1-α subunit (HIF1A), and neuropilin 1 levels were examined with the ELISA method. In the study, 90 samples taken from subjects, including pre-treatment preeclampsia (n =35), post-treatment preeclampsia (n = 35), and healthy control (n = 20) groups were evaluated. The data obtained from the study was analyzed with SPSS 22.0. As a result of the statistical analysis, pre-treatment nesfatin-1, and ezrin levels were found significantly lower than post-treatment and the healthy control group and HIF-1A levels were found significantly higher. As a result of these analyses, pre-treatment and post-treatment PP13 levels were found to be significantly higher than the healthy control group.Considering the results obtained from the study, we can say that nestin, ezrin, HIF1A, PP13, and NRP1 are important biomarkers for predicting preeclampsia.